19-7899168-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_025061.6(LRRC8E):c.646G>A(p.Glu216Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_025061.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC8E | NM_025061.6 | c.646G>A | p.Glu216Lys | missense_variant | 3/3 | ENST00000306708.11 | NP_079337.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC8E | ENST00000306708.11 | c.646G>A | p.Glu216Lys | missense_variant | 3/3 | 1 | NM_025061.6 | ENSP00000306524.5 | ||
LRRC8E | ENST00000618098.4 | c.646G>A | p.Glu216Lys | missense_variant | 4/4 | 3 | ENSP00000479953.1 | |||
ENSG00000214248 | ENST00000539278.1 | n.4375C>T | non_coding_transcript_exon_variant | 1/1 | 6 | |||||
LRRC8E | ENST00000600345.1 | c.*38G>A | downstream_gene_variant | 4 | ENSP00000473127.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251166Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135812
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461682Hom.: 0 Cov.: 38 AF XY: 0.0000358 AC XY: 26AN XY: 727124
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.646G>A (p.E216K) alteration is located in exon 3 (coding exon 2) of the LRRC8E gene. This alteration results from a G to A substitution at nucleotide position 646, causing the glutamic acid (E) at amino acid position 216 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at